Loading company details...
Beta
Latest Form 4 (Sep 22, 2026): Crespo Blas Coll (CHIEF MEDICAL OFFICER): Tax Withholding of 10,626 shares, $124.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Crespo Blas Coll, CHIEF MEDICAL OFFICER | Tax Withholding | 10,626 | $124.0K |
| Sep 3, 2026 | Xichen Lin, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 17,817 | $6.1K |
| Aug 20, 2026 | Xichen Lin, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 11,817 | $4.0K |
| Aug 7, 2026 | John Joseph Berrios, Chief Commercial Officer | Grant/Award | 140,766 | n/a |
| Aug 5, 2026 | Xichen Lin, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 11,817 | $4.0K |
| Jul 24, 2026 | FMR LLC | Sale | 1,367 | $68.4K |
| Jul 15, 2026 | Xichen Lin, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 23,634 | $8.0K |
| Jun 30, 2026 | Xichen Lin, CHIEF SCIENTIFIC OFFICER | Exercise/Conversion | 23,634 | $8.0K |
| Jun 18, 2026 | Angus C. Russell | Grant/Award | 39,453 | n/a |
| Jun 18, 2026 | Ted W. Love | Grant/Award | 39,453 | n/a |